Covid-19 therapy could come by end of year, vaccine in 2021
Electron microscope image of Covid-19 (yellow) emerging from the surface of cells (blue/pink) cultured in a US lab
Keystone / Niaid- Rml/national Institutes O
Swiss pharma and business insiders predict that an effective drug therapy against Covid-19 will be available by the end of this year, but a vaccine might take a year longer than that.
This content was published on
2 minutes
Keystone-SDA/swissinfo.ch/sm
Português
pt
Tratamento para coronavírus pode chegar no final do ano, vacina em 2021
“In the best-case scenario, a drug could be available before the end of 2020,” said on Monday Francesco De Rubertis, director and co-founder of Medicxi, a Geneva-based venture capital company that invests in biotechnology.
In an interview with the Swiss newspaper Le TempsExternal link, De Rubertis said, “We should know by the end of 2020 if any of the vaccines tested are promising. If the answer is positive, a vaccine may appear in the second half of 2021, possibly in the third quarter.”
He noted that this time frame would be “exceptionally short” – less than two years after the appearance of Covid-19 – when it normally takes five to seven years to develop a vaccine. De Rubertis predicts that a vaccine will come from a large pharma or a large biotech company rather than a start-up.
Spring 2021?
Meanwhile, the chairman of the board of the Swiss reinsurance company Swiss Re reckons a vaccine will be ready “in the first quarter of 2021 at the earliest – and then it will have to go into mass production very quickly”. In an interview published by the CH-Media newspaper group on Tuesday, Walter Kielholz said that the world would not return to normal until there was a vaccine against Covid-19.
However, he said he could imagine lockdown measures being relaxed soon. “Why jewellery shops or furniture stores, for example, have to remain closed is beyond me. They could resume operations if the hygiene regulations were observed. This also applies to other shops, such as clothing stores,” he said.
During a briefing on Tuesday, Margaret Harris of the Geneva-based World Health OrganizationExternal link said, “We shouldn’t really be expecting to see the vaccine for 12 months or longer.”
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
This story has been amended to clarify that Francesco De Reubertis predicts a drug therapy will be available by the end of 2020, and a vaccine in 2021.
Popular Stories
More
Multinational companies
Azeri fossil-fuel cash cow brings controversy to Switzerland
Environment minister outlines Swiss efforts to limit global warming
This content was published on
Switzerland will do its part to achieve the goal of limiting global warming to 1.5 degrees Celcius, said Environment Minister Albert Rösti, who's attending COP29 in Baku.
This content was published on
Switzerland remains by a large margin the European champion of train travel, both in terms of the number of journeys per person and the number of kilometres travelled. Switzerland remains by a large margin the European champion of train travel, both in terms of the number of journeys per person and the number of kilometres travelled. Switzerland remains by a large margin the European champion of train travel, both in terms of the number of journeys per person and the number of kilometres travelled.
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Balancing hope and science in the search for a coronavirus cure
This content was published on
The debate surrounding the antimalarial drug hydroxychloroquine epitomises companies' balancing act between hope and scientific realities.
Start-up firms feel frozen out of coronavirus bailout funds
This content was published on
Start-ups are falling through the cracks of a state-sponsored funding scheme designed to keep companies afloat during the coronavirus crisis.
With no prospects for profits, big pharma neglects new infectious diseases
This content was published on
More companies are shifting resources away from emerging infectious diseases into more lucrative areas like cancer. What does this mean for Covid-19?
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.